期刊文献+

膜融合脂质体作为疫苗载体的研究进展 被引量:3

Development of membrane fusogenic lipesomes as the vector of vaccine
下载PDF
导出
摘要 目的 对病毒 脂质体融合形成的膜融合脂质体的融合机制、制备方法、抗原导入、抗原呈递及其作为疫苗导入载体的研究进展做一分析和总结。方法 总结近几年来有关方面的文献。结果 膜融合脂质体可以将抗原导入到细胞质中 ,并诱发强烈的CTL反应。膜融合脂质体的融合为融合蛋白的空间结构发生变化所致。结论 膜融合脂质体是一种非常有发展前景的抗原导入载体。
出处 《中国药学杂志》 CAS CSCD 北大核心 2003年第10期734-737,共4页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献31

  • 1胡英,金一,王华,李敏伟.阳离子膜融合脂质体介导反义寡核苷酸在Hela细胞中的转染实验研究[J].药学学报,2002,37(11):892-896. 被引量:8
  • 2Lamb RA. Paramyxovirus fusion: a hypothesis for changes[J ].Virology, 1993,197( 1 ) : 1.
  • 3Hughson FM. Structural characterization of viral fusion protein[J ]. Curr Biol, 1995,5(3) :265.
  • 4Ruigrok RW, Barge A, Durrer P, et al. Membrane interaction of influenza virus M1 protein[J]. Virology,2000,267(2) :289.
  • 5Takimoto T, Taylor GL, Crennell SJ, et al. Crystallization of newcastle disease virus heamagglutinin-neuraminidase glycoprotein[J ]. Virology ,2000,270( 1 ) .'208.
  • 6Cameiro FA, Ferradosa AS, Da Poian AT. Low pH-induced conformational changes in Ve. sicular stomatitis virus glycoprotein involve dramatic structure reorganization[J ]. J Biol Chem ,2001,276(1):62.
  • 7Ramalho-Santos J, Lima MC, Nir S. Partial fusion activity of influenza virus toward liposomes and erythrocyte ghosts is distinct from viral inactivation[ J ]. J Biol Chem, 1996,271 (39) : 23902.
  • 8Gunter-Ausborn S, Schoen P, Bartoldus I, et al. Role of hemagglutinin surface density in the initial stages of influenza virus fusion., lack of evidence for cooperativity[J ]. J Virol,2000,74(6) :2714.
  • 9Tomasi M, Baiocchi M, Moscufo N, et al. Mild proteolysis inducea a ready-to-fuse state on Sendai virus envelope[J]. FEBS Later, 1998,423(3): 286.
  • 10Stone HJ, Morrison TG. Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells[J]. J Virol, 1997,71 (9) :6287.

二级参考文献11

  • 1[1]Son KK, Tkach D, Hall KJ. Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA [J]. Biochim Biophy Act, 2000,29(1-2):6-10.
  • 2[2]Mario CF, Nigel CP. Major limitations in the use of cationic liposomes for DNA delivery [J]. Int J Pharm, 1998,162(1-2):159-170.
  • 3[3]Nakanishi M, Uchida T, Sugawa H, et al. Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus) [J]. Exp Cell Res, 1985,159(2):399-409.
  • 4[4]Mizuguchi H, Nakanishi M, Nakanishi T, et al. Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy [J]. Br J Cancer, 1996,73(4):472-476.
  • 5[5]Mizuguchi H, Nakanishi T, Kondoh M, et al. Fusion of Sendai virus with liposome depends on only F protein, but not HN protein [J]. Virus Res, 1999,59(2):191-201.
  • 6[6]Dzau VJ, Mann MJ, Morishita R, et al. Fusogenic viral liposome for gene therapy in cardiovascular diseases [J]. Proc Natl Acad Sci USA, 1996,93(21):1421-1425.
  • 7[7]Nakanishi M, Mizuguchi H, Ashihara K, et al. Gene transfer vectors based on Sendai virus [J]. J Controlled Release, 1998,54(1):61-68.
  • 8[8]Gao X, Huang L. A novel cationic liposome reagent for efficiency transfection of mannalian cells [J]. Biochem Biophys Res Common, 1991,179(1):280-285.
  • 9[9]Lee KD, Nir S, Papahadjopoulos D. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes [J]. Biochemistry, 1993,32(3):889-899.
  • 10[10]Mizuguchi H, Nakagawa T, Nakanishi M, et al. Efficient gene transfer into mannalian cells using fusogenic liposome [J]. Biochem Biophys Res Common, 1996,218(1):402-407.

共引文献7

同被引文献36

  • 1易学文,吴霞.免疫脂质体的研究进展[J].四川理工学院学报(自然科学版),2004,17(3):133-136. 被引量:4
  • 2吴小宁,王军,欧阳五庆.脂质体在生物领域内的研究进展[J].动物医学进展,2005,26(6):44-47. 被引量:3
  • 3孙波,杨骅,李兆申,屠振兴,龚燕芳,杜奕奇.幽门螺杆菌UreB-NAP-HpaA三价DNA疫苗的构建及免疫原性初步研究[J].第二军医大学学报,2005,26(6):636-638. 被引量:3
  • 4丁玉玲,马淑贤,卢秀荣,王海波,霍玉书.人参皂甙脂质体(GSL)的研制[J].中国药学杂志,1995,30(7):414-417. 被引量:35
  • 5穆筱梅.脂质体在化妆品中的应用[J].广东化工,2006,33(2):20-21. 被引量:5
  • 6Fabani M M,Gargini R,Taira M C,et al.Study of in vitro stability of liposomes and in vivo antibody response to antigen associated with liposomes containing GM1 after oral and subcutaneous immunization.J Liposome Res,2002,12 (1 ~2):13~27
  • 7Ninomiya A,Ogasawara K,Kajino K,et al.Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.Vaccine,2002,20 (25 ~26):3123 ~3129
  • 8Lee C K,Weltzin R,Thomas W D,et al.Oral immunization with recombinant Helicobacter pyloriurease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.J Infect Dis,1995,172 (2):161 ~172
  • 9Ermak T H,Giannasca P J,Nichols R,et al.Immunization of mice with urease vaccine affords protection agaist Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class Ⅱ restricted responses.J Exp Med,1998,188 (10):2277~2288
  • 10Stuttin P,Wilson J,Kosaka T,et al.Therapeutic immunization agaist Helicobacter pylori infection in the absence of antibodies,Immunol Cell Biol,2000,78 (1):28~30

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部